Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Collplant Biotechnologies Ltd ADR (CLGN)

Collplant Biotechnologies Ltd ADR (CLGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,211
  • Shares Outstanding, K 11,086
  • Annual Sales, $ 15,640 K
  • Annual Income, $ 240 K
  • 60-Month Beta N/A
  • Price/Sales 95.34
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CLGN with:

Options Overview Details

View History
  • Implied Volatility 87.03% ( -37.77%)
  • Historical Volatility 61.92%
  • IV Percentile 77%
  • IV Rank 53.90%
  • IV High 156.25% on 09/23/22
  • IV Low 6.08% on 02/04/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 3
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 70
  • Open Int (30-Day) 71

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate -0.31
  • Number of Estimates 1
  • High Estimate -0.31
  • Low Estimate -0.31
  • Prior Year -0.29
  • Growth Rate Est. (year over year) -6.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.27 +14.52%
on 11/25/22
7.00 -30.14%
on 11/02/22
-1.41 (-22.38%)
since 10/28/22
3-Month
4.27 +14.52%
on 11/25/22
9.13 -46.44%
on 09/02/22
-3.11 (-38.88%)
since 08/26/22
52-Week
4.27 +14.52%
on 11/25/22
18.30 -73.28%
on 12/28/21
-13.11 (-72.83%)
since 11/26/21

Most Recent Stories

More News
CollPlant to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 17

/PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative human-collagen based...

CLGN : 4.89 (+3.82%)
CollPlant to present at the Dawson James Small Cap Growth Conference on October 12

/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for...

CLGN : 4.89 (+3.82%)
CollPlant to Present at the International Conference on Biofabrication 2022 in Tuscany, Italy

/PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative human collagen-based technologies and products...

CLGN : 4.89 (+3.82%)
CollPlant Biotechnologies Provides Business Updates and Second Quarter 2022 Financial Results

/PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing innovative human collagen-based technologies...

CLGN : 4.89 (+3.82%)
CollPlant Advances its 3D Bioprinted Regenerative Breast Implants into Porcine Study

/PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for tissue...

CLGN : 4.89 (+3.82%)
New Strong Sell Stocks for April 22nd

BBBY, CLGN, and ADAP have been added to the Zacks Rank #5 (Strong Sell) List on April 22, 2022

BBBY : 3.11 (+2.30%)
ADAP : 2.15 (+1.90%)
CLGN : 4.89 (+3.82%)
RION Appoints Alisa Lask as Chief Commercial Officer

RION, a biotechnology company headquartered in Rochester, Minnesota pioneering new innovations in exosomes for therapeutic and aesthetic indications, today announced the appointment of Alisa Lask as Chief...

CLGN : 4.89 (+3.82%)
NEPH : 1.0101 (+1.01%)
CollPlant's rhCollagen BioInk Used by Technion Researchers to Develop 3D Bioprinted Vascularized Tissue Constructs

/PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products for...

CLGN : 4.89 (+3.82%)
36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021

RALEIGH, NC / ACCESSWIRE / October 4, 2021 / The Fall Harvest - Best Ideas from the Buy-Side will take place on October 5th - 8th, 2021, where 36 SmallCap, MicroCap and NanoCap public companies will be...

CLGN : 4.89 (+3.82%)
NLSP : 0.8401 (-3.44%)
TGCB : 0.5100 (+7.32%)
OSS.VN : 0.400 (+2.56%)
OSSIF : 0.2990 (+0.67%)
MITI : 0.0640 (+1.59%)
AYRO : 0.5900 (+3.51%)
IMAC : 1.0100 (+2.00%)
CR : 105.09 (-0.20%)
MYO : 0.5801 (-1.66%)
BASA : 0.0760 (-3.92%)
ADIL : 0.2724 (+1.60%)
3D Systems and CollPlant Enter Co-development Agreement to Deliver Bioprinted Solutions for Improved Breast Reconstruction Treatments

ROCK HILL, S.C. and REHOVOT, Israel, June 22, 2021 (GLOBE NEWSWIRE) -- Today, 3D Systems (NYSE:DDD) and CollPlant Biotechnologies (NASDAQ:CLGN) announced they have signed a co-development agreement for...

DDD : 9.14 (+0.11%)
CLGN : 4.89 (+3.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CollPlant Biotechnologies Ltd. is a regenerative medicine company. It is focused on 3D bioprinting of tissues and organs, medical aesthetics and on developing and commercializing tissue repair products for orthobiologics and advanced wound care markets. CollPlant Biotechnologies Ltd., formerly knonw...

See More

Key Turning Points

3rd Resistance Point 5.62
2nd Resistance Point 5.34
1st Resistance Point 5.12
Last Price 4.89
1st Support Level 4.62
2nd Support Level 4.34
3rd Support Level 4.12

See More

52-Week High 18.30
Fibonacci 61.8% 12.94
Fibonacci 50% 11.28
Fibonacci 38.2% 9.63
Last Price 4.89
52-Week Low 4.27

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar